Top

Published in:

01-04-2014 | Research Article

The volume and duration of wound drainage are independent prognostic factors for breast cancer

Authors: Yan Zhang, Hua Gao, Wei Gao

Published in: Tumor Biology | Issue 4/2014

Abstract

Drain insertion is routinely done after breast cancer surgery. However, the prognostic value of suction drains in breast cancer is still unknown. This study aimed to reveal the prognostic value of drain insertion in breast cancer. A total of 296 female breast cancer patients undergoing surgery were retrospectively recruited. The correlation of drainage volume as well as drain duration with clinicopathological parameters and prognosis was assessed statistically. We found that breast cancer patients with a drainage volume of >240 ml had a better overall survival time. Breast cancer patients with more than 5 days postoperative drain duration would have better survival time. In addition, both the volume and duration of wound drainage are independent prognostic factors in multivariate analysis. Therefore, the volume of drainage as well as drain duration is a potential novel prognostic marker for breast cancer.

Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin. 2013;63:11–30.PubMedCrossRef

Goldhirsch A, Wood WC, Gelber RD, Coates AS, Thurlimann B, Senn HJ. Meeting highlights: updated international expert consensus on the primary therapy of early breast cancer. J Clin Oncol. 2003;21:3357–65.PubMedCrossRef

Kuroi K, Shimozuma K, Taguchi T, Imai H, Yamashiro H, Ohsumi S, et al. Pathophysiology of seroma in breast cancer. Breast Cancer. 2005;12:288–93.PubMedCrossRef

Woodworth PA, McBoyle MF, Helmer SD, Beamer RL. Seroma formation after breast cancer surgery: incidence and predicting factors. Am Surg. 2000;66:444–50. discussion 450–441.PubMed

Sakkary MA. The value of mastectomy flap fixation in reducing fluid drainage and seroma formation in breast cancer patients. World J Surg Oncol. 2012;10:8.PubMedCentralPubMedCrossRef

Lumachi F, Brandes AA, Burelli P, Basso SM, Iacobone M, Ermani M. Seroma prevention following axillary dissection in patients with breast cancer by using ultrasound scissors: a prospective clinical study. Eur J Surg Oncol. 2004;30:526–30.PubMedCrossRef

Shamley DR, Barker K, Simonite V, Beardshaw A. Delayed versus immediate exercises following surgery for breast cancer: a systematic review. Breast Cancer Res Treat. 2005;90:263–71.PubMedCrossRef

Kontos M, Petrou A, Prassas E, Tsigris C, Roy P, Trafalis D, et al. Pressure dressing in breast surgery: is this the solution for seroma formation? J BUON. 2008;13:65–7.PubMed

Ruggiero R, Procaccini E, Piazza P, Docimo G, Iovino F, Antoniol G, et al. Effectiveness of fibrin glue in conjunction with collagen patches to reduce seroma formation after axillary lymphadenectomy for breast cancer. Am J Surg. 2008;196:170–4.PubMedCrossRef

10.

He XD, Guo ZH, Tian JH, Yang KH, Xie XD. Whether drainage should be used after surgery for breast cancer? A systematic review of randomized controlled trials. Med Oncol. 2011;28 Suppl 1:S22–30.PubMedCrossRef

11.

Talbot ML, Magarey CJ. Reduced use of drains following axillary lymphadenectomy for breast cancer. ANZ J Surg. 2002;72:488–90.PubMedCrossRef

12.

Moss JP. Historical and current perspectives on surgical drainage. Surg Gynecol Obstet. 1981;152:517–27.PubMed

13.

Agrawal A, Ayantunde AA, Cheung KL. Concepts of seroma formation and prevention in breast cancer surgery. ANZ J Surg. 2006;76:1088–95.PubMedCrossRef

14.

Saratzis A, Soumian S, Willetts R, Rastall S, Stonelake PS. Use of multiple drains after mastectomy is associated with more patient discomfort and longer postoperative stay. Clin Breast Cancer. 2009;9:243–6.PubMedCrossRef

15.

Barton A, Blitz M, Callahan D, Yakimets W, Adams D, Dabbs K. Early removal of postmastectomy drains is not beneficial: results from a halted randomized controlled trial. Am J Surg. 2006;191:652–6.PubMedCrossRef

16.

Gupta R, Pate K, Varshney S, Goddard J, Royle GT. A comparison of 5-day and 8-day drainage following mastectomy and axillary clearance. Eur J Surg Oncol. 2001;27:26–30.PubMedCrossRef

17.

Singletary SE, Allred C, Ashley P, Bassett LW, Berry D, Bland KI, et al. Revision of the American Joint Committee on Cancer staging system for breast cancer. J Clin Oncol. 2002;20:3628–36.PubMedCrossRef

18.

Iovino F, Auriemma PP, Ferraraccio F, Antoniol G, Barbarisi A. Preventing seroma formation after axillary dissection for breast cancer: a randomized clinical trial. Am J Surg. 2012;203:708–14.PubMedCrossRef

19.

Lin YP, Yin WJ, Yan TT, Zhou LH, Di GH, Wu J, et al. Risk factors for postoperative seromas in Chinese breast cancer patients. Chin Med J (Engl). 2011;124:1300–4.

20.

Su P, Zhang Q, Yang Q. Immunohistochemical analysis of metadherin in proliferative and cancerous breast tissue. Diagn Pathol. 2010;5:38.PubMedCentralPubMedCrossRef

21.

Li X, Kong X, Chen X, Zhang N, Jiang L, Ma T, et al. LAPTM4B allele *2 is associated with breast cancer susceptibility and prognosis. PLoS One. 2012;7:e44916.PubMedCentralPubMedCrossRef

22.

Hormbrey E, Han C, Roberts A, McGrouther DA, Harris AL. The relationship of human wound vascular endothelial growth factor (VEGF) after breast cancer surgery to circulating VEGF and angiogenesis. Clin Cancer Res. 2003;9:4332–9.PubMed

23.

Wu FP, Hoekman K, Meijer S, Cuesta MA. VEGF and endostatin levels in wound fluid and plasma after breast surgery. Angiogenesis. 2003;6:255–7.PubMedCrossRef

24.

Tagliabue E, Agresti R, Carcangiu ML, Ghirelli C, Morelli D, Campiglio M, et al. Role of HER2 in wound-induced breast carcinoma proliferation. Lancet. 2003;362:527–33.PubMedCrossRef

25.

Fisher B, Gunduz N, Coyle J, Rudock C, Saffer E. Presence of a growth-stimulating factor in serum following primary tumor removal in mice. Cancer Res. 1989;49:1996–2001.PubMed

26.

Hofer SO, Shrayer D, Reichner JS, Hoekstra HJ, Wanebo HJ. Wound-induced tumor progression: a probable role in recurrence after tumor resection. Arch Surg. 1998;133:383–9.PubMedCrossRef

27.

Barwell J, Campbell L, Watkins RM, Teasdale C. How long should suction drains stay in after breast surgery with axillary dissection? Ann R Coll Surg Engl. 1997;79:435–7.PubMedCentralPubMed

28.

Horgan K, Benson EA, Miller A, Robertson A. Early discharge with drain in situ following axillary lymphadenectomy for breast cancer. Breast. 2000;9:90–2.PubMedCrossRef

Title: The volume and duration of wound drainage are independent prognostic factors for breast cancer
Authors: Yan Zhang
Hua Gao
Wei Gao
Publication date: 01-04-2014
Publisher: Springer Netherlands
Published in: Tumor Biology / Issue 4/2014
Print ISSN: 1010-4283
Electronic ISSN: 1423-0380
DOI: https://doi.org/10.1007/s13277-013-1470-z

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

At a glance: The STEP trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 4/2014

Quantitative assessment of the association between three polymorphisms in FAS and FASL gene and breast cancer risk

p21 overexpression sensitizes osteosarcoma U2OS cells to cisplatin via evoking caspase-3 and Bax/Bcl-2 cascade

Hexokinase 2 overexpression promotes the proliferation and survival of laryngeal squamous cell carcinoma

Clinicopathological and prognostic significance of chemokine receptor CXCR4 overexpression in patients with esophageal cancer: a meta-analysis

MiR-495 regulates proliferation and migration in NSCLC by targeting MTA3

Meta-analysis: eating frequency and risk of colorectal cancer

Keynote webinar | Spotlight on antibody–drug conjugates in cancer